NANOG and neoplasm: Using immunohistochemistry, Fu et al. evaluated the expression of OCT4, SOX2, and NANOG in oral cancer and showed that the expression of OCT4 and SOX2 increased with decreased tumor stage and size as well as the absence of lymph node metastasis (Fu et al., 2016).